Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Mass Spectrom Rev ; 32(5): 386-98, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23832591

RESUMO

Transcription factors (TFs) are essential for the expression of all proteins, including those involved in human health and disease. However, TFs are resistant to proteomic characterization because they are frequently masked by more abundant proteins due to the limited dynamic range of capillary liquid chromatography-tandem mass spectrometry and protein database searching. Purification methods, particularly strategies that exploit the high affinity of TFs for DNA response elements (REs) on gene promoters, can enrich TFs prior to proteomic analysis to improve dynamic range and penetrance of the TF proteome. For example, trapping of TF complexes specific for particular REs has been achieved by recovering the element DNA-protein complex on solid supports. Additional methods for improving dynamic range include two- and three-dimensional gel electrophoresis incorporating electrophoretic mobility shift assays and Southwestern blotting for detection. Here we review methods for TF purification and characterization. We fully expect that future investigations will apply these and other methods to illuminate this important but challenging proteome.


Assuntos
Proteômica/métodos , Espectrometria de Massas em Tandem/métodos , Fatores de Transcrição/química , Animais , Cromatografia Líquida/métodos , Bases de Dados de Proteínas , Eletroforese/métodos , Humanos , Elementos de Resposta , Fatores de Transcrição/genética , Fatores de Transcrição/isolamento & purificação , Fatores de Transcrição/metabolismo , Ativação Transcricional
2.
J Vet Pharmacol Ther ; 36(3): 222-8, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22607033

RESUMO

The purpose of this study was to assess the clinical effects of dexmedetomidine, both alone and combined with pethidine or butorphanol, in cats. A prospective randomized blind study was performed. Thirty cats were randomly assigned to three groups of 10 animals: D: dexmedetomidine (20 µg/kg IM); DP: dexmedetomidine (10 µg/kg IM) and pethidine (2.5 mg/kg IM); DB: dexmedetomidine (10 µg/kg IM) and butorphanol (0.4 mg/kg IM). Quality of sedation, analgesia, muscle relaxation and the possibility of performing some clinical procedures were compared using a multifactorial scale. Sedation, analgesia and muscle relaxation increased progressively over time and did not differ in the three protocols. The three protocols facilitated the completion of several clinical procedures. The clinical variables studied showed a similar behaviour in the three protocols and remained close to the baseline, except for a drop in heart rate in protocol D. In conclusion, dexmedetomidine, either alone or combined with pethidine or butorphanol, offers suitable sedation, analgesia and relaxation to perform various clinical procedures in cats.


Assuntos
Butorfanol/farmacologia , Gatos/fisiologia , Dexmedetomidina/farmacologia , Hipnóticos e Sedativos/farmacologia , Meperidina/farmacologia , Animais , Butorfanol/administração & dosagem , Dexmedetomidina/administração & dosagem , Quimioterapia Combinada , Feminino , Hipnóticos e Sedativos/administração & dosagem , Masculino , Meperidina/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...